Cargando…
Minimal change disease related to rifampicin presenting with acute renal failure during treatment for latent tuberculosis infection: A case report
RATIONALE: The standard drugs used to treat tuberculosis are rifampicin and isoniazid. These agents are usually safe and inexpensive for short-term use in treatment of latent tuberculosis infection, but sometimes cause adverse renal effects, including minimal change disease (MCD). PATIENT CONCERNS:...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392561/ https://www.ncbi.nlm.nih.gov/pubmed/29851774 http://dx.doi.org/10.1097/MD.0000000000010556 |